0.7023
price down icon2.08%   -0.0149
after-market Dopo l'orario di chiusura: .70 -0.0023 -0.33%
loading
Precedente Chiudi:
$0.7172
Aprire:
$0.7004
Volume 24 ore:
2.06M
Relative Volume:
0.62
Capitalizzazione di mercato:
$129.31M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
17.56
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
-3.24%
1M Prestazione:
+17.23%
6M Prestazione:
-84.15%
1 anno Prestazione:
-89.23%
Intervallo 1D:
Value
$0.6861
$0.7579
Intervallo di 1 settimana:
Value
$0.6861
$0.784
Portata 52W:
Value
$0.5271
$7.105

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Nome
Ironwood Pharmaceuticals Inc
Name
Telefono
617-621-7722
Name
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Dipendente
253
Name
Cinguettio
@ironwoodpharma
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
IRWD's Discussions on Twitter

Confronta IRWD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
0.7023 129.31M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
14.60 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.19 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.35 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.37 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.64 20.17B 16.54B -1.64B 749.00M -1.45

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-15 Downgrade Jefferies Buy → Hold
2025-04-15 Downgrade Wells Fargo Overweight → Equal Weight
2025-04-14 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 Iniziato Leerink Partners Market Perform
2024-08-08 Downgrade CapitalOne Overweight → Equal Weight
2024-01-17 Iniziato Craig Hallum Buy
2023-12-14 Iniziato Wells Fargo Overweight
2023-11-09 Iniziato Jefferies Buy
2023-09-28 Iniziato JMP Securities Mkt Outperform
2022-09-02 Iniziato CapitalOne Overweight
2022-04-22 Iniziato Piper Sandler Overweight
2020-09-30 Downgrade Wells Fargo Overweight → Equal Weight
2020-06-17 Iniziato Northland Capital Outperform
2019-07-10 Ripresa Credit Suisse Neutral
2019-03-27 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2019-02-25 Aggiornamento H.C. Wainwright Sell → Neutral
2019-01-24 Aggiornamento JP Morgan Underweight → Neutral
2018-11-07 Downgrade Credit Suisse Outperform → Neutral
2018-11-07 Downgrade JP Morgan Neutral → Underweight
2018-07-23 Iniziato H.C. Wainwright Sell
2018-05-09 Downgrade Morgan Stanley Equal-Weight → Underweight
2018-01-05 Downgrade BofA/Merrill Buy → Underperform
2017-12-06 Downgrade Mizuho Buy → Neutral
2017-07-21 Downgrade JP Morgan Overweight → Neutral
2017-05-03 Iniziato Wells Fargo Outperform
2017-04-07 Reiterato Mizuho Buy
2017-02-22 Reiterato Barclays Equal Weight
2016-11-04 Reiterato Mizuho Buy
2016-10-24 Reiterato Wedbush Neutral
2016-10-10 Reiterato Mizuho Buy
2016-09-27 Reiterato WallachBeth Hold
Mostra tutto

Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie

pulisher
Jun 12, 2025

Ironwood Pharma Elects Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 06, 2025

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Ironwood Pharmaceuticals Inc (IRWD) Is A Good Stock To Invest In - Stocksregister

Jun 05, 2025
pulisher
May 29, 2025

Ameriprise Financial Inc. Trims Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

May 29, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock - Investing.com Australia

May 20, 2025
pulisher
May 19, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 19, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025
pulisher
May 10, 2025

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call - MSN

May 10, 2025
pulisher
May 09, 2025

Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price at $4.78 - Defense World

May 09, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ironwood: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook - Investing.com

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Maintains LINZESS Sales Outlook Amid Pricing Challenges | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood (IRWD) Reports Q1 Revenue Shortfall, Ending Quarter with Increased Cash Reserves | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Q1 2025 Earnings: EPS of -$0.23 Misses Estimate, Revenue Falls Short at $41.14 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire

May 07, 2025
pulisher
May 01, 2025

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for - Yahoo

May 01, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sci - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference | IRWD Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025 - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock News - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares rise - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - ADVFN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 Guidance and Raises Adjusted EBITDA - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support - itemonline.com

Apr 22, 2025
pulisher
Apr 18, 2025

Ironwood looks for strategic options after regulatory hurdle for lead drug - MSN

Apr 18, 2025
pulisher
Apr 18, 2025

Ironwood Pharmaceuticals to Explore Strategic Alternatives to Maximize Value for Stockholders - marketscreener.com

Apr 18, 2025
pulisher
Apr 17, 2025

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Ironwood Shares Tank on Regulatory Update for Apraglutide - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Setback After FDA Request - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges A - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD Stock News - GuruFocus

Apr 16, 2025

Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Gaskins Tammi L
Chief Commercial Officer
May 16 '25
Sale
0.58
2,563
1,487
242,596
$14.43
price up icon 1.05%
$9.18
price up icon 2.80%
$128.00
price up icon 1.84%
$290.91
price up icon 1.24%
drug_manufacturers_specialty_generic RDY
$14.94
price down icon 0.60%
$16.64
price down icon 0.72%
Capitalizzazione:     |  Volume (24 ore):